Sener G, Satiroğlu H, Topaloğlu U, Keyer-Uysal M
Department of Pharmacology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey.
Fundam Clin Pharmacol. 2001 Feb;15(1):19-22. doi: 10.1046/j.1472-8206.2001.00007.x.
The small intestine is highly sensitive to oxygen free radical-induced injury. Post-ischemic intestinal tissue damage appears to be due to the formation of oxygen radicals. Free radical initiated lipid peroxidation (LP) following intestinal ischemia/reperfusion (I/R) may disrupt mucosal integrity. Indirectly, the radicals trigger the accumulation of neutrophils within the affected tissue, initiating inflammatory processes that lead to severe mucosal lesions. In the present study we investigated the effect of pentoxifylline (PTX), a potent inhibitor of tumour necrosis factor production, on I/R induced intestinal injury. Wistar albino rats were divided into four groups: (1) Sham operation (S); (2) Sham operation + PTX (50 mg/kg i.v.) (S + PTX); (3) 1 h ischemia + 2 h reperfusion (I/R); and (4) I/R + PTX. Animals were sacrificed at the end of the reperfusion period and ileum samples were obtained. Malondialdehyde (MDA) levels, an end product of LP, glutathione (GSH) levels, a key antioxidant, and myeloperoxidase (MPO) activity (an index of polymorphonuclear neutrophils) stimulation, were determined in ileum homogenates. The results of the present study indicate that ischemia/reperfusion results in a significant increase in MDA content and MPO activity with a significant decrease in GSH content. Treatment with PTX returns these biomarkers to control values. A mechanism of this protective effect may involve inhibition of neutrophil oxidative burst.
小肠对氧自由基诱导的损伤高度敏感。缺血后肠道组织损伤似乎是由于氧自由基的形成。肠道缺血/再灌注(I/R)后自由基引发的脂质过氧化(LP)可能会破坏黏膜完整性。自由基间接引发中性粒细胞在受影响组织内的积聚,启动导致严重黏膜损伤的炎症过程。在本研究中,我们研究了肿瘤坏死因子产生的强效抑制剂己酮可可碱(PTX)对I/R诱导的肠道损伤的影响。将Wistar白化大鼠分为四组:(1)假手术组(S);(2)假手术+PTX(50mg/kg静脉注射)组(S+PTX);(3)1小时缺血+2小时再灌注组(I/R);(4)I/R+PTX组。在再灌注期结束时处死动物并获取回肠样本。测定回肠匀浆中LP的终产物丙二醛(MDA)水平、关键抗氧化剂谷胱甘肽(GSH)水平以及髓过氧化物酶(MPO)活性(多形核中性粒细胞的指标)刺激情况。本研究结果表明,缺血/再灌注导致MDA含量和MPO活性显著增加,GSH含量显著降低。PTX治疗可使这些生物标志物恢复至对照值。这种保护作用的机制可能涉及抑制中性粒细胞的氧化爆发。